Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway

BACKGROUND: Pulmonary fibrosis is a progressive and irreversible disease for which therapeutic options are currently limited. A recent in vivo study showed that tenofovir, a nucleotide analogue reverse transcriptase inhibitor, had direct antifibrotic effects on skin and liver fibrosis. Another study...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lingxia, Zhao, Jing, Zhou, Li, Chen, Jie, Ma, Yuanyuan, Yu, Yanyan, Cheng, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647111/
https://www.ncbi.nlm.nih.gov/pubmed/31331325
http://dx.doi.org/10.1186/s12931-019-1102-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647111/
https://www.ncbi.nlm.nih.gov/pubmed/31331325
http://dx.doi.org/10.1186/s12931-019-1102-2

Ejemplares similares